Accelerating cancer immunotherapy discovery

AI-powered Design of T-cell-Receptor-based 
Cancer Immunotherapies

Predict

In silico predictions of therapy side-effects during pre-clinical development

Engineer

Suggestions for molecular modifications to prevent side-effects

Learn

Integration of lab data to improve predictions over time

Meet The Team

Federico Paoletti

CEO & CO-FOUNDER

PhD in Molecular and Computational
Oncology (University of Oxford, UK) and deep
expertise in mathematical modelling and
molecular biophysics.

Andrea Mambrini

CTO & CO-FOUNDER

PhD in Bio-Inspired Computation (University of
Birmingham, UK) and several years of hands-on
experience building cutting-edge AI software
tools across the space, media, automotive and
marketing industries.

Interested?

Contact us using the form below.

Email:

info@exogene.co.uk

Reg. Number:

12293407

Address:

Exogene Limited, Internatonal House, 24 Holborn Viaduct, EC1A 2BN, London, United Kingdom

Scroll to Top